➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Mallinckrodt
McKinsey
Dow
McKesson

Last Updated: September 26, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DIFLUPREDNATE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Difluprednate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00405496 ↗ Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis Completed Sirion Therapeutics, Inc. Phase 2 2000-03-01 The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of uveitis.
NCT00406341 ↗ Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation Completed Sirion Therapeutics, Inc. Phase 3 2004-04-01 The purpose of this phase 3 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation.
NCT00406497 ↗ Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation Completed Sirion Therapeutics, Inc. Phase 2 2003-04-01 The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation.
NCT00406887 ↗ Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis Completed Sirion Therapeutics, Inc. Phase 3 2002-08-01 The purpose of this phase 3 confirmatory study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of treatment of uveitis.
NCT00407056 ↗ Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis Completed Sirion Therapeutics, Inc. Phase 3 2002-08-01 The purpose of this phase 3 open-labeled study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of severe uveitis.
NCT00407225 ↗ Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation Completed Sirion Therapeutics, Inc. Phase 2 1999-12-01 The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Difluprednate

Condition Name

Condition Name for Difluprednate
Intervention Trials
Inflammation 8
Cataract 3
Uveitis 3
Cataracts 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Difluprednate
Intervention Trials
Inflammation 11
Uveitis 7
Cataract 5
Uveitis, Anterior 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Difluprednate

Trials by Country

Trials by Country for Difluprednate
Location Trials
United States 14
Mexico 3
Argentina 1
India 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Difluprednate
Location Trials
Texas 3
California 2
Florida 2
Missouri 2
South Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Difluprednate

Clinical Trial Phase

Clinical Trial Phase for Difluprednate
Clinical Trial Phase Trials
Phase 4 6
Phase 3 11
Phase 2 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Difluprednate
Clinical Trial Phase Trials
Completed 16
Not yet recruiting 4
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Difluprednate

Sponsor Name

Sponsor Name for Difluprednate
Sponsor Trials
Sirion Therapeutics, Inc. 12
Alcon Research 4
Aravind Eye Care System 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Difluprednate
Sponsor Trials
Industry 19
Other 9
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Colorcon
Dow
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.